In a new study published in the AJR, pre-scan same day eGFR testing revealed that out of 10,256 patients who had these labs, only 1.4% displayed levels below the recommended cutoff.

The communication cited concerns of thyroid dysfunction in pediatric patients after administering the imaging agent. 

Use of such agents has diminished in recent years, but there is still a great need for oral contrast among oncology patients, experts report in AJR. 

Though adverse events after subcutaneous extravasation of contrast media during CT scans are not common, serious complications can occur, experts report in Academic Radiology.

Historically, sensitivity to iodinated contrast media was not a risk factor for adverse reactions to gadolinium-based contrast agents, experts explained this week in Radiology.

The rat model showed no clinical evidence of neurotoxicity after doses above diagnostic levels were administered, but further research is needed in humans, experts reported in Radiology.

Gadopiclenol was shown to require 50% less gadolinium compared to other commonly used agents, according to Phase 3 clinical studies.

Mount Sinai doctors presented their simple system during the American Heart Association's annual meeting.